Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to show presence of cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. Investigators will describe a significant link between this factors and hallucinations in a sample of non-psychotic children. The results of this sample will be comparing to another group of children of the same age, sex and diagnosis, but without hallucination. Finally, investigators will control the persistence of hallucination on the first group after a six month period.


Clinical Trial Description

Background: Hallucinations are a common symptom in pediatric population without psychotic syndrome. Vulnerability, co morbidity and risk factor are already been described. Investigators will study the cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. The goal of the study is to find a social cognition our emotional impairment to explain auditory hallucinations without psychotic symptoms. Methods: Sample of out non-psychotic patients aged six to eighteen years old with auditory hallucinations were recruited with a self report scale created for this study. Mini International Neuropsychiatric Interview (MINI)-kids interview and "psychosis" section od Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia for school age chidlren) were conducted to determine Diagnostic and Statistical Manual of Mental Disorders (DSM) IV diagnoses. All children patient were spend specifics social cognition (NeuroPsychologic assessment NEPSY II) and emotional (ifferential Emotions Scale (DES) IV, Beliefs About Voices Questionnaire Revised (BAVQ-R)) scales. Each child results will be compared to child result of the same age, sex and diagnosis but without hallucination that passed the same specifics scales. All of child will be control after a six month period to evaluate auditory hallucination persistence and diagnosis evolution. The total period of the study will be twelve month. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02567500
Study type Interventional
Source Fondation Lenval
Contact
Status Completed
Phase N/A
Start date July 7, 2015
Completion date July 7, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT06155695 - Auditory Control Enhancement (ACE) in Schizophrenia N/A
Completed NCT00763841 - Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations Phase 1
Active, not recruiting NCT04661163 - CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy N/A
Completed NCT01478880 - Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations Phase 2
Completed NCT01015001 - A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine Phase 3
Withdrawn NCT02240446 - Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients N/A
Completed NCT02670291 - Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation N/A
Completed NCT01963676 - Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia N/A
Completed NCT00870909 - Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia N/A